ExonHit Therapeutics SA, Mitsubishi Pharma deal

Mitsubishi received a site license to ExonHit's Safe-Hit microarray technology for evaluating the toxicity of compounds. The product uses ExonHit's differential analysis of transcripts with alternativ...